Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Validity of the International HIV dementia scale in Brazil.

Rodrigues RA, Oliveira RL, Grinsztejn B, Silva MT.

Arq Neuropsiquiatr. 2013 Jun;71(6):376-9. doi: 10.1590/0004-282X20130042.

2.

Validity of the International HIV Dementia Scale in South Africa.

Joska JA, Westgarth-Taylor J, Hoare J, Thomas KG, Paul R, Myer L, Stein DJ.

AIDS Patient Care STDS. 2011 Feb;25(2):95-101. doi: 10.1089/apc.2010.0292. Epub 2011 Jan 7.

PMID:
21214343
3.

Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.

Skinner S, Adewale AJ, DeBlock L, Gill MJ, Power C.

HIV Med. 2009 Apr;10(4):246-52. doi: 10.1111/j.1468-1293.2008.00679.x. Epub 2009 Jan 23.

4.

The HIV Dementia Scale: predictive power in mild dementia and HAART.

Bottiggi KA, Chang JJ, Schmitt FA, Avison MJ, Mootoor Y, Nath A, Berger JR.

J Neurol Sci. 2007 Sep 15;260(1-2):11-5. Epub 2007 May 4.

PMID:
17482212
5.

[An exploratory study on the diagnostic cutoff value of International HIV-associated Dementia Scale in minority ethnic groups with different educational levels, in Guangxi].

Zhao TT, Feng QM, Liang H, Tang XY, Wei B.

Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Nov;32(11):1101-4. Chinese.

PMID:
22336543
6.

Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.

Marin-Webb V, Jessen H, Kopp U, Jessen AB, Hahn K.

PLoS One. 2016 Dec 19;11(12):e0168225. doi: 10.1371/journal.pone.0168225. eCollection 2016.

7.

The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E.

AIDS. 2005 Sep 2;19(13):1367-74.

PMID:
16103767
8.

A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.

Joska JA, Witten J, Thomas KG, Robertson C, Casson-Crook M, Roosa H, Creighton J, Lyons J, McArthur J, Sacktor NC.

AIDS Behav. 2016 Aug;20(8):1621-31. doi: 10.1007/s10461-016-1316-y.

9.
10.

The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon.

Njamnshi AK, Djientcheu Vde P, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WE.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):393-7.

PMID:
19186351
11.

Prevalence of neurocognitive disorders and depression in a Brazilian HIV population.

Troncoso FT, Conterno Lde O.

Rev Soc Bras Med Trop. 2015 Jul-Aug;48(4):390-8. doi: 10.1590/0037-8682-0034-2015.

12.

Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery.

de Almeida SM, Kamat R, Cherner M, Umlauf A, Ribeiro CE, de Pereira AP, Franklin D, Heaton RK, Ellis RJ.

J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):332-338. doi: 10.1097/QAI.0000000000001224. Erratum in: J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):e64.

13.

Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection.

Lopardo GD, Bissio E, Iannella Mdel C, Crespo AD, Garone DB, Cassetti LI.

J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):488-92. doi: 10.1097/QAI.0b013e3181b06348.

PMID:
19654553
14.

HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project.

Ku NS, Lee Y, Ahn JY, Song JE, Kim MH, Kim SB, Jeong SJ, Hong KW, Kim E, Han SH, Song JY, Cheong HJ, Song YG, Kim WJ, Kim JM, Smith DM, Choi JY.

HIV Med. 2014 Sep;15(8):470-7. doi: 10.1111/hiv.12137. Epub 2014 Feb 24.

15.

Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.

Lawler K, Mosepele M, Ratcliffe S, Seloilwe E, Steele K, Nthobatsang R, Steenhoff A.

J Int AIDS Soc. 2010 Apr 20;13:15. doi: 10.1186/1758-2652-13-15.

16.

Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study.

Atashili J, Gaynes BN, Pence BW, Tayong G, Kats D, O'donnell JK, Ndumbe PM, Njamnshi AK.

BMC Neurol. 2013 Jul 15;13:86. doi: 10.1186/1471-2377-13-86.

17.

Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.

Cross S, Önen N, Gase A, Overton ET, Ances BM.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1114-22. doi: 10.1007/s11481-013-9505-1. Epub 2013 Oct 10.

18.

Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South Africa.

Goodkin K, Hardy DJ, Singh D, Lopez E.

J Neuropsychiatry Clin Neurosci. 2014 Fall;26(4):352-8. doi: 10.1176/appi.neuropsych.13080178.

19.

Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature.

Zipursky AR, Gogolishvili D, Rueda S, Brunetta J, Carvalhal A, McCombe JA, Gill MJ, Rachlis A, Rosenes R, Arbess G, Marcotte T, Rourke SB.

AIDS. 2013 Sep 24;27(15):2385-401. doi: 10.1097/QAD.0b013e328363bf56. Review.

20.

Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND.

Chalermchai T, Valcour V, Sithinamsuwan P, Pinyakorn S, Clifford D, Paul RH, Tipsuk S, Fletcher JL, Degruttola V, Ratto-Kim S, Hutchings N, Shikuma C, Ananworanich J; SEARCH 007 and 011 study groups.

J Neurovirol. 2013 Apr;19(2):137-43. doi: 10.1007/s13365-013-0151-4. Epub 2013 Mar 13.

Supplemental Content

Support Center